4/17/24 16:14 | 4/4/24 | SRZN | Surrozen, Inc./De | DE | Health | BioPrd | Biological Products, (No Diag | Column Group III Gp, LP | CA | T | | P.a | 3,000 | 15.50 | 0 | 194 | 46 | 617 | I | | | | | | | | | | | | | | |
4/8/24 16:23 | 4/4/24 | SRZN | Surrozen, Inc./De | | Health | BioPrd | Biological Products, (No Diag | Column Group III Gp, LP | CA | T | | P.d | 3,000 | 15.50 | 0 | 194 | 45 | 628 | I | | | | | | | | | | | | | | |
2/14/24 16:15 | 2/12/24 | TNYA | Tenaya Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Column Group III Gp, LP | CA | T | | P | 10,000 | 4.50 | 0 | 2,222 | 11 | 23,000 | I | | | | | | | | | | | | | | |
3/14/23 16:12 | 3/10/23 | TNYA | Tenaya Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Column Group III Gp, LP | CA | T | | P | 18 | 2.60 | 0 | 7 | 0 | 20,777 | I | | | | | | | | | | | | | | |
2/10/23 16:32 | 2/8/23 | TNYA | Tenaya Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Column Group III Gp, LP | CA | T | | P | 3,900 | 2.60 | 0 | 1,500 | 8 | 20,771 | I | | | | | | | | | | | | | | |
1/23/23 16:25 | 1/19/23 | TNYA | Tenaya Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Column Group III Gp, LP | CA | T | | P | 174 | 2.50 | 0 | 70 | 0 | 19,271 | I | | | | | | | | | | | | | | |
1/19/23 16:18 | 1/17/23 | TNYA | Tenaya Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Column Group III Gp, LP | CA | T | | P.m | 465 | 2.51 | 0 | 185 | 1 | 19,201 | I | | | | | | | | | | | | | | |
11/23/22 16:12 | 11/21/22 | TNYA | Tenaya Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Column Group III Gp, LP | CA | T | | P | 25,000 | 2.60 | 0 | 9,615 | 102 | 19,016 | I | | | | | | | | | | | | | | |